UBS analyst Radi Sultan raised the firm’s price target on C3 AI (AI) to $28 from $26 and keeps a Neutral rating on the shares. C3 AI and Baker Hughes (BKR) announced the renewal and expansion of their joint venture agreement through mid-2028, while C3 guided fiscal 2026 revenue growth of 20% at the midpoint, the analyst tells investors in a research note. The renewal is a positive as this takes a key risk off the table, but the lack of visibility around revenue given the mix dynamic is the firm’s key hurdle to getting more constructive, the analyst says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AI:
- Sell Rating on C3ai Due to Growth Concerns and Uncertain Long-term Benefits of Baker Hughes Contract
- C3.ai Faces Financial and Market Challenges Amidst AI Advancements: Analyst Recommends Sell Rating
- C3.ai Reports Record Growth and Strategic Partnerships
- Closing Bell Movers: Nvidia gains 4% on earnings, lifting other semis
- C3 AI sees FY26 revenue $447.5M-$484.5M consensus $466.1M